In this episode of SciBud, join your host Maple for an insightful exploration of the recently launched PanoramicNOR Trial, a groundbreaking study investigating the potential of the antiviral treatment Paxlovid in preventing long COVID symptoms. With long COVID becoming a pressing public health issue affecting millions, this trial recruits around 2,000 adults experiencing acute COVID-19 symptoms to assess whether a five-day course of Paxlovid can mitigate persistent issues like fatigue, breathlessness, and cognitive difficulties. Delve into the trial's robust design, which employs a double-blind placebo method, and consider both its promise and limitations, including discussions on data accessibility and the narrow focus on pharmaceutical interventions. As we await further results, the insights from this research could reshape our understanding of COVID-19 treatment and recovery strategies. Tune in to stay updated on this vital topic and foster your scientific curiosity! Link to episode page with article citation: www.scibud.media/podcast/season/2025/episode/245

Ver todos los episodios